We asked Shaun Martin PhD, a senior postdoctural scientist researching Parkinson’s Disease at KU Leuven, to tell us more about his role, motivation and research. His responses were both eye-opening and touching. Read his full interview here.
Sarah van Veen remembers the moment her lab experiment went blue, as if it was yesterday! It was September 2016 and she was two years into her biomedical science doctorate studying how a dysfunctional protein in brain cells contributed to the development of Parkinson’s Disease. “I wasn’t really expecting to see blue that … Continued
A few years ago, Liesbeth attended a motivational seminar given by Patrick & Anne-Marie. Their positive attitude was so inspiring that she decided to help the Demoucelle Parkinson Charity.
Portrait of Patrick Cras, Professor of Neurology & Head of Service at the UZ Antwerp.
Since being diagnosed in 2013, Michael Broad has taken part in a number of clinical trials to help find ways of alleviating symptoms and slowing progression of Parkinson’s.
We don’t typically think much about walking or keeping balance unless we have trouble with these activities. That’s because we don’t have to think about them, it’s automatic. Parkinson’s can interrupt these automatic connections and cause walking and balance problems, especially in people who live with the disease for many years.
After a Parkinson’s diagnosis, one of the first questions a person asks is, “What is going to happen to me?” People with Parkinson’s disease understandably want to know how their symptoms will change over time.
Many clinical trials use a placebo comparison to evaluate the effect of a new drug or therapy. Some people get the active intervention and some get an inactive “fake” treatment that looks the same as the real thing. What is a placebo? Is it a good thing? Can a placebo make you feel worse? From Michael J. Fox Foundation for Parkinson’s Research website.
Doctor Rachel Dolhun is movement disorder specialist and vice president of medical communications at the MJFF. In this video, she talks about depression and anxiety in Parkinson’s disease. How are depression and anxiety treated? What are the tips to manage depression and anxiety?
Results are in from a study of glial cell line-derived neurotrophic factor (GDNF), a “brain fertilizer” that some scientists believe may help protect dopamine cells and improve Parkinson’s symptoms. Many news reports are citing the findings as miraculous, but the response could be due to placebo effect.